期刊文献+

调强适形放疗联合替莫唑胺治疗恶性脑胶质瘤的临床观察 被引量:4

Clinical Effect of Intensity Modulated Radiation Therapy Combined with Concomitant and Adjuvant Temozolomide in the Treatment for Malignant Glioma
原文传递
导出
摘要 [目的]观察调强适形放疗(IMRT)联合替莫唑胺(TMZ)治疗恶性脑胶质瘤的临床疗效。[方法]28例术后病理诊断为高级别胶质瘤(WHOⅢ~Ⅳ)的患者,术后放射治疗为全脑左、右对穿野常规照射(WBRT)并后程调强加量照射。常规放射治疗剂量为40Gy/20f/4w,调强放射治疗剂量为20Gy/4f/2w;放疗同步口服替莫唑胺(TMZ)治疗6个周期,之后再接受至少2个周期的常规TMZ治疗。[结果]中位生存时间及无进展生存时间分别为11.5个月和7.2个月;1年总生存率为53.57%,2年总生存率为25.00%。常见的不良反应为恶心、呕吐,血液学毒性是白细胞和血小板下降,但仅限于Ⅰ~Ⅱ度。[结论]IMRT同步TMZ治疗恶性脑胶质瘤,安全有效,不良反应轻微。 [Purpose] To investigate clinical efficacy of intensity modulated radiation therapy (IMRT) combined with concomitant and adjuvant temozolomide (TMZ) in the treatment for malignant glioma. [Methods] A total of 28 malignant glioma cases (grade Ⅲ~Ⅳ) pathologically proved were enrolled.After 40Gy/20f/4w by conventional fractionation irradiation delivered through whole brain left/right fields, IMRT was started as a boost.The irradiation dose of doseescalation was 20Gy/4f/2w; TMZ was given for 6 cycles at the same time,then at least 2 cycles by the routine treatment. [Results ] The median survival time and the progression free survival time were 11.5 months and 7.2 months respectively. I- year and 2- year survival rate were 53.57% and 25.00% respectively.The common side effects were nausea,vomiting; hematologic toxicity was white cells and platelets decreased(degree Ⅰ~Ⅱ ). [Conclusion] IMRT plus concomitant and adjuvant TMZ for malignant glioma is safe and effective,with mild adverse reactions.
机构地区 山西省人民医院
出处 《中国肿瘤》 CAS 2013年第3期238-240,共3页 China Cancer
关键词 恶性胶质瘤 调强适形放疗 替莫唑胺 malignant glioma intensity modulated radiation therapy temozolomide
  • 相关文献

参考文献8

  • 1Brandes AA,Tosoni A,Franceschi E,et al. Glioblastoma in adults[J]. Crit Rev Oncol Hematol,2008,67(2):139-152.
  • 2Piroth MD,Gagel B,Pinkawa M,et al. Postoperative ra- diotherapy of glioblastoma muhiforme: analysis and critical assessent of different treatment strategies and predictive factors [J]. Strahlenther Onkol, 2007,183 (12):695-702.
  • 3Ulm AJ 3rd,Friedman WA,Bradshaw P,et al. Radiosurgery in the treatment of malignant gliomas: the University of Florida experience[J]. Neurosurgery, 2005,57(3):512-517.
  • 4Stupp R, Mason WP,van den Bent MJ ,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblas- toma [J]. N Engl J Med,2005,352(10):987-996.
  • 5Versehuur AC,Grill J,Lelouch-Tubiana A,et al. Temo- zolomide in paediatric high-grade glioma: a key for combi- nation therapy?[J]. Br J Cancer,2004,91(3):425-429.
  • 6Ashby L,LaRoeca R,Ryken T. Treatment of brain tumors [J]. N Engl J Med,2005,352(22):2350-2353.
  • 7张玉宇,曲雅勤,姜新,赵钦,郭潇,冯奇.调强适形放射治疗联合替莫唑胺化疗治疗恶性脑胶质瘤的近期疗效及安全性评价[J].吉林大学学报(医学版),2012,38(3):571-574. 被引量:12
  • 8Athanassiou H,Synodinou M,Maragoudakis E,et al. Ran- domized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme[J]. J Clin Oncol, 2005,23 (10): 2372-2377.

二级参考文献14

  • 1杨冬,王忠诚,邱晓光,江涛,张亚卓.放、化疗同步治疗高级别胶质瘤[J].中华神经外科疾病研究杂志,2007,6(5):450-453. 被引量:20
  • 2谷铣之,殷蔚伯,余子豪,等.肿瘤放射治疗学[M].4版北京:中国协和医科大学出版社,2007:1122-1125.
  • 3Stupp R, Masn WP, van den Bent MJ, et al. Radiontherapy plus concomitant and adjuvant temozolomide for glioblastoma[J]. NEngIJ Med, 2005, 352(10): 987 -996.
  • 4Iuchi T, Hatano K, Narita Y, et al. Hypofractionated high- dose irradiation for the treatment of malignant astrocytomas using simultaneous integrated boost technique by IMRT[J]. Int J Radiat Oneol Biol Phys, 2006, 64(5) : 1317-1324.
  • 5CorsaP, Pafisi S, Raguso A, et al. Temozolimide and radiotherapy as first-line treatment of high'grade gliomas[J]. Tumor, 2006, 92(4): 299- 305.
  • 6van Rin J, Heimans JJ, van den Berg J, et al. Survival of human glioma cells treated with various combination of temozolomide and X-rays[J]. Int J Radiat Oncol Biol Phys,2000, 47(3): 779-784.
  • 7Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase study: 5-year analysis of the EORTC- NCIC trial[J]. Lancet Oncol, 2009, 10(5) : 459-466.
  • 8Papuashvili GS, Gagua RO, Ninua NG. Temozolomide-a new antitumor preparation in the treatment of central nervous system malignant tumors [J]. Georgian Med News, 2006(134), 31-34.
  • 9王若峥,王多明.调强放疗与替莫唑胺联合治疗颅内恶性胶质瘤16例临床分析[J].广西医科大学学报,2008,25(5):796-797. 被引量:6
  • 10陈焕雄,曹作为,李钢,陈敏,符俊骐,高宁.脑胶质瘤选择性颈动脉化疗42例临床分析[J].海南医学院学报,2010,16(2):202-204. 被引量:5

共引文献11

同被引文献33

引证文献4

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部